Cormorant Asset Management, LLC Insider Trading $AXNX Axonics, Inc.
Get free email notifications about insider trading for Cormorant Asset Management, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Cormorant Asset Management, LLC. Cormorant Asset Management, LLC is 10% Owner in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and 10% Owner in Apellis Pharmaceuticals, Inc. ($APLS) and in Atea Pharmaceuticals, Inc. ($AVIR) and in Avidity Biosciences, Inc. ($RNA) and 10% Owner in Axonics Modulation Technologies, Inc. ($AXNX) and 10% Owner in Turning Point Therapeutics, Inc. ($TPTX) and 10% Owner in Kezar Life Sciences, Inc. ($KZR) and in Prometheus Biosciences, Inc. ($RXDX) and in Rain Therapeutics Inc. ($RAIN) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and in Olema Pharmaceuticals, Inc. ($OLMA) and in BioAtla, Inc. ($BCAB) and Director in Biomea Fusion, Inc. ($BMEA).
Cormorant Asset Management, LLC in Axonics, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Cormorant Asset Management, LLC: 10% Owner
Holdings: 599,999 shares
Latest Transaction: Nov 02 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Cormorant Asset Management, LLC in Axonics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APLS, AVIR, RNA, AXNX, BCAB, BMEA, KZR, KNSA, OLMA, RXDX, RAIN, TPTX, YMTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 02 2018 | AXNX | Axonics Modulation ... | Cormorant Asset Management, LP | 10% Owner | Option Exercise | C | 0.00 | 552,495 | 0 | 0 | |
| Nov 02 2018 | AXNX | Axonics Modulation ... | Cormorant Asset Management, LP | 10% Owner | Option Exercise | C | 0.00 | 599,999 | 0 | 0 | |
| Nov 02 2018 | AXNX | Axonics Modulation ... | Cormorant Asset Management, LP | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 1,285,827 | 1.2 M to 1.3 M (+11.57 %) |
| Nov 02 2018 | AXNX | Axonics Modulation ... | Cormorant Asset Management, LP | 10% Owner | Buy | C | 0.00 | 552,495 | 0 | 1,152,494 | 600 K to 1.2 M (+92.08 %) |
| Nov 02 2018 | AXNX | Axonics Modulation ... | Cormorant Asset Management, LP | 10% Owner | Buy | C | 0.00 | 599,999 | 0 | 599,999 | 0 to 600 K |
Page: 1